Physical Characterization and Biodistribution of Cisplatin Loaded in Surfactant Modified-Hybrid Nanoparticles Using Polyethylene Oxide-b-Polymethacrylic Acid

Purpose: Conjugating cisplatin into hybrid nanoparticles is intended to enhance tumor accumulation in cancer therapy due to drug interaction with polymer and prevent premature drug release because of the presence of a lipid layer. Methods: Hybrid nanoparticles composed of polyethylene oxide-b-pol...

Full description

Saved in:
Bibliographic Details
Main Author: Andang Miatmoko, -
Format: Article PeerReviewed
Language:English
English
English
English
Published: Tabriz University of Medical Sciences 2020
Subjects:
Online Access:https://repository.unair.ac.id/123626/4/C-05%20Artikel.pdf
https://repository.unair.ac.id/123626/2/C-05%20Kualitas%20Karil.pdf
https://repository.unair.ac.id/123626/3/C-05%20Similarity.pdf
https://repository.unair.ac.id/123626/1/C-05%20Korespondensi.pdf
https://repository.unair.ac.id/123626/
https://apb.tbzmed.ac.ir/Article/apb-29003
https://doi.org/10.34172/apb.2021.086
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
English
English
Description
Summary:Purpose: Conjugating cisplatin into hybrid nanoparticles is intended to enhance tumor accumulation in cancer therapy due to drug interaction with polymer and prevent premature drug release because of the presence of a lipid layer. Methods: Hybrid nanoparticles composed of polyethylene oxide-b-polymethacrylic acid, egg phosphatidylcholine, and surfactant, i.e. sodium cholate/sodium deoxycholate/Tween 80, were prepared by the injection method. Cisplatin was subsequently loaded by incubating the polymer-drug mixtures at the molar ratio of carboxylate ions of 2:1. Results: The results showed that the addition of surfactants produced particle sizes between 33 and 52 nm. The addition of cisplatin increased the ζ-potential to slightly positive charges with encapsulation efficiencies of 5%-18%. An in vivo biodistribution study of mice identified a cisplatin plasma concentration of sodium cholate-modified hybrid nanoparticles 10 times higher than cisplatin solution, thus producing high tumor accumulation. Conclusion: Conjugating cisplatin into sodium cholate-modified hybrid nanoparticles improves its accumulation in tumors.